$ICPT Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in INTERCEPT PHARMACEUTICALS, INC..

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview

Overview of all insider trading transactions in INTERCEPT PHARMACEUTICALS, INC.. Get notifications about new insider transactions in INTERCEPT PHARMACEUTICALS, INC. for free.

Page: < prev 1 ... 2 3 4 5 6 7 8 9 ... 13 next >

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Sep 22 2016	ICPT	INTERCEPT PHARMACE ...	Pruzanski Mark	CEO & President	Buy	M	8.67	26,589	230,439	579,314	552.7 K to 579.3 K (+4.81 %)
Aug 25 2016	ICPT	INTERCEPT PHARMACE ...	Bright Lisa	President of Intern ...	Sell	S	159.00	246	39,114	18,460	18.7 K to 18.5 K (-1.32 %)
Aug 02 2016	ICPT	INTERCEPT PHARMACE ...	McMinn Rachel	Chief Strategy Offi ...	Sell	S	176.57	125	22,071	13,861	14 K to 13.9 K (-0.89 %)
Jul 21 2016	ICPT	INTERCEPT PHARMACE ...	AKKARAJU SRINIVAS	Director	Option Exercise	A	145.22	1,598	232,062	1,598
Jul 21 2016	ICPT	INTERCEPT PHARMACE ...	AKKARAJU SRINIVAS	Director	Grant	A	0.00	1,204	0	13,246	12 K to 13.2 K (+10.00 %)
Jul 21 2016	ICPT	INTERCEPT PHARMACE ...	SANTINI GINO	Director	Option Exercise	A	145.22	1,598	232,062	1,598
Jul 21 2016	ICPT	INTERCEPT PHARMACE ...	SANTINI GINO	Director	Grant	A	0.00	1,204	0	2,504	1.3 K to 2.5 K (+92.62 %)
Jul 21 2016	ICPT	INTERCEPT PHARMACE ...	Fundaro Paolo	Director	Option Exercise	A	145.22	1,598	232,062	1,598
Jul 21 2016	ICPT	INTERCEPT PHARMACE ...	Fundaro Paolo	Director	Grant	A	0.00	1,204	0	10,075	8.9 K to 10.1 K (+13.57 %)
Jul 21 2016	ICPT	INTERCEPT PHARMACE ...	WELCH DANIEL G	Director	Option Exercise	A	145.22	1,598	232,062	1,598
Jul 21 2016	ICPT	INTERCEPT PHARMACE ...	WELCH DANIEL G	Director	Grant	A	0.00	1,204	0	2,504	1.3 K to 2.5 K (+92.62 %)
Jul 21 2016	ICPT	INTERCEPT PHARMACE ...	SBLENDORIO GLENN	Director	Option Exercise	A	145.22	1,598	232,062	1,598
Jul 21 2016	ICPT	INTERCEPT PHARMACE ...	SBLENDORIO GLENN	Director	Grant	A	0.00	1,204	0	2,306	1.1 K to 2.3 K (+109.26 %)
Jul 21 2016	ICPT	INTERCEPT PHARMACE ...	Benatti Luca	Director	Option Exercise	A	145.22	1,598	232,062	1,598
Jul 21 2016	ICPT	INTERCEPT PHARMACE ...	Benatti Luca	Director	Grant	A	0.00	1,204	0	3,146	1.9 K to 3.1 K (+62.00 %)
Jul 21 2016	ICPT	INTERCEPT PHARMACE ...	Gottesdiener Keith Michael	Director	Option Exercise	A	145.22	3,196	464,123	3,196
Jul 21 2016	ICPT	INTERCEPT PHARMACE ...	Gottesdiener Keith Michael	Director	Grant	A	0.00	2,407	0	2,407	0 to 2.4 K
Jul 21 2016	ICPT	INTERCEPT PHARMACE ...	BRADBURY DANIEL	Director	Option Exercise	A	145.22	3,196	464,123	3,196
Jul 21 2016	ICPT	INTERCEPT PHARMACE ...	BRADBURY DANIEL	Director	Grant	A	0.00	2,407	0	2,407	0 to 2.4 K
Jul 19 2016	ICPT	INTERCEPT PHARMACE ...	Pruzanski Mark	CEO & President	Option Exercise	M	9.82	12,500	122,779	0
Jul 19 2016	ICPT	INTERCEPT PHARMACE ...	Pruzanski Mark	CEO & President	Payment of Exercise	F	148.73	7,341	1,091,827	552,725	560.1 K to 552.7 K (-1.31 %)
Jul 19 2016	ICPT	INTERCEPT PHARMACE ...	Pruzanski Mark	CEO & President	Buy	M	9.82	12,500	122,779	560,066	547.6 K to 560.1 K (+2.28 %)
Jul 07 2016	ICPT	INTERCEPT PHARMACE ...	Duncan Barbara Gayle	Chief Accounting Of ...	Sell	S	145.11	146	21,186	30,808	31 K to 30.8 K (-0.47 %)
Jul 07 2016	ICPT	INTERCEPT PHARMACE ...	Shapiro David	CMO and EVP - Devel ...	Sell	S	145.11	163	23,653	48,391	48.6 K to 48.4 K (-0.34 %)
Jul 07 2016	ICPT	INTERCEPT PHARMACE ...	Pruzanski Mark	CEO & President	Sell	S	145.11	714	103,608	547,566	548.3 K to 547.6 K (-0.13 %)
Jul 07 2016	ICPT	INTERCEPT PHARMACE ...	McMinn Rachel	Chief Strategy Offi ...	Sell	S	145.11	106	15,382	13,986	14.1 K to 14 K (-0.75 %)
Jul 07 2016	ICPT	INTERCEPT PHARMACE ...	Bright Lisa	See Remarks	Sell	S	145.11	155	22,492	18,706	18.9 K to 18.7 K (-0.82 %)
Jul 06 2016	ICPT	INTERCEPT PHARMACE ...	Kapadia Sandip	Chief Financial Off ...	Option Exercise	A	146.36	18,000	2,634,480	18,000
Jul 06 2016	ICPT	INTERCEPT PHARMACE ...	Kapadia Sandip	Chief Financial Off ...	Grant	A	0.00	15,000	0	15,000	0 to 15 K
May 26 2016	ICPT	INTERCEPT PHARMACE ...	Bright Lisa	See Remarks	Sell	S	137.50	251	34,512	18,855	19.1 K to 18.9 K (-1.31 %)
May 17 2016	ICPT	INTERCEPT PHARMACE ...	AKKARAJU SRINIVAS	Director	Option Exercise	M	21.50	1,500	32,250	2,499
May 17 2016	ICPT	INTERCEPT PHARMACE ...	AKKARAJU SRINIVAS	Director	Buy	M	21.50	1,500	32,250	12,042	10.5 K to 12 K (+14.23 %)
May 04 2016	ICPT	INTERCEPT PHARMACE ...	McMinn Rachel	Chief Strategy Offi ...	Sell	S	147.49	130	19,174	14,087	14.2 K to 14.1 K (-0.91 %)
Apr 06 2016	ICPT	INTERCEPT PHARMACE ...	Shapiro David	CMO and EVP - Devel ...	Sell	S	130.76	165	21,575	48,546	48.7 K to 48.5 K (-0.34 %)
Apr 06 2016	ICPT	INTERCEPT PHARMACE ...	Pruzanski Mark	CEO & President	Sell	S	130.76	708	92,578	548,248	549 K to 548.2 K (-0.13 %)
Apr 06 2016	ICPT	INTERCEPT PHARMACE ...	McMinn Rachel	Chief Strategy Offi ...	Sell	S	130.76	104	13,599	14,217	14.3 K to 14.2 K (-0.73 %)
Apr 06 2016	ICPT	INTERCEPT PHARMACE ...	Bright Lisa	See Remarks	Sell	S	130.76	153	20,006	19,106	19.3 K to 19.1 K (-0.79 %)
Apr 06 2016	ICPT	INTERCEPT PHARMACE ...	Duncan Barbara Gayle	Chief Financial Off ...	Sell	S	130.76	144	18,829	30,948	31.1 K to 30.9 K (-0.46 %)
Feb 29 2016	ICPT	INTERCEPT PHARMACE ...	Bright Lisa	See Remarks	Sell	S	115.22	241	27,768	19,259	19.5 K to 19.3 K (-1.24 %)
Feb 12 2016	ICPT	INTERCEPT PHARMACE ...	Pruzanski Mark	See Remarks	Option Exercise	A	95.74	30,500	2,920,070	30,500
Feb 12 2016	ICPT	INTERCEPT PHARMACE ...	Pruzanski Mark	See Remarks	Grant	A	0.00	23,300	0	552,856	529.6 K to 552.9 K (+4.40 %)
Feb 12 2016	ICPT	INTERCEPT PHARMACE ...	McMinn Rachel	Chief Strategy Offi ...	Option Exercise	A	95.74	8,800	842,512	8,800
Feb 12 2016	ICPT	INTERCEPT PHARMACE ...	McMinn Rachel	Chief Strategy Offi ...	Grant	A	0.00	6,700	0	14,321	7.6 K to 14.3 K (+87.91 %)
Feb 12 2016	ICPT	INTERCEPT PHARMACE ...	Bright Lisa	See Remarks	Option Exercise	A	95.74	10,200	976,548	10,200
Feb 12 2016	ICPT	INTERCEPT PHARMACE ...	Bright Lisa	See Remarks	Grant	A	0.00	7,800	0	19,500	11.7 K to 19.5 K (+66.67 %)
Feb 12 2016	ICPT	INTERCEPT PHARMACE ...	Duncan Barbara Gayle	Chief Financial Off ...	Option Exercise	A	95.74	8,100	775,494	8,100
Feb 12 2016	ICPT	INTERCEPT PHARMACE ...	Duncan Barbara Gayle	Chief Financial Off ...	Grant	A	0.00	6,200	0	31,092	24.9 K to 31.1 K (+24.91 %)
Feb 12 2016	ICPT	INTERCEPT PHARMACE ...	Shapiro David	CMO and EVP - Devel ...	Option Exercise	A	95.74	10,200	976,548	10,200
Feb 12 2016	ICPT	INTERCEPT PHARMACE ...	Shapiro David	CMO and EVP - Devel ...	Grant	A	0.00	7,800	0	48,711	40.9 K to 48.7 K (+19.07 %)
Feb 03 2016	ICPT	INTERCEPT PHARMACE ...	McMinn Rachel	Chief Strategy Offi ...	Sell	S	103.56	128	13,256	7,621	7.7 K to 7.6 K (-1.65 %)
Jan 14 2016	ICPT	INTERCEPT PHARMACE ...	Bright Lisa	See Remarks	Sell	S	129.99	104	13,519	11,700	11.8 K to 11.7 K (-0.88 %)
Jan 14 2016	ICPT	INTERCEPT PHARMACE ...	Bright Lisa	See Remarks	Sell	S	124.78	624	77,862	11,804	12.4 K to 11.8 K (-5.02 %)
Jan 05 2016	ICPT	INTERCEPT PHARMACE ...	McMinn Rachel	Chief Strategy Offi ...	Sell	S	145.90	469	68,429	7,749	8.2 K to 7.7 K (-5.71 %)
Jan 05 2016	ICPT	INTERCEPT PHARMACE ...	Duncan Barbara Gayle	Chief Financial Off ...	Option Exercise	M	0.00	1,298	0	0
Jan 05 2016	ICPT	INTERCEPT PHARMACE ...	Duncan Barbara Gayle	Chief Financial Off ...	Sell	S	145.90	428	62,447	24,892	25.3 K to 24.9 K (-1.69 %)
Jan 05 2016	ICPT	INTERCEPT PHARMACE ...	Duncan Barbara Gayle	Chief Financial Off ...	Sell	S	145.90	40	5,836	25,320	25.4 K to 25.3 K (-0.16 %)
Jan 05 2016	ICPT	INTERCEPT PHARMACE ...	Duncan Barbara Gayle	Chief Financial Off ...	Buy	M	0.00	1,298	0	25,360	24.1 K to 25.4 K (+5.39 %)
Jan 05 2016	ICPT	INTERCEPT PHARMACE ...	Shapiro David	CMO and EVP - Devel ...	Option Exercise	M	0.00	1,623	0	0
Jan 05 2016	ICPT	INTERCEPT PHARMACE ...	Shapiro David	CMO and EVP - Devel ...	Sell	S	145.90	496	72,368	40,911	41.4 K to 40.9 K (-1.20 %)
Jan 05 2016	ICPT	INTERCEPT PHARMACE ...	Shapiro David	CMO and EVP - Devel ...	Sell	S	145.90	37	5,398	41,407	41.4 K to 41.4 K (-0.09 %)
Jan 05 2016	ICPT	INTERCEPT PHARMACE ...	Shapiro David	CMO and EVP - Devel ...	Buy	M	0.00	1,623	0	41,444	39.8 K to 41.4 K (+4.08 %)
Jan 05 2016	ICPT	INTERCEPT PHARMACE ...	Pruzanski Mark	CEO & President	Option Exercise	M	0.00	4,868	0	0
Jan 05 2016	ICPT	INTERCEPT PHARMACE ...	Pruzanski Mark	CEO & President	Sell	S	145.90	125	18,238	529,556	529.7 K to 529.6 K (-0.02 %)
Jan 05 2016	ICPT	INTERCEPT PHARMACE ...	Pruzanski Mark	CEO & President	Sell	S	145.90	2,001	291,953	529,681	531.7 K to 529.7 K (-0.38 %)
Jan 05 2016	ICPT	INTERCEPT PHARMACE ...	Pruzanski Mark	CEO & President	Buy	M	0.00	4,868	0	531,682	526.8 K to 531.7 K (+0.92 %)
Dec 22 2015	ICPT	INTERCEPT PHARMACE ...	Shapiro David	CMO and EVP - Devel ...	Option Exercise	M	31.90	219	6,986	22,281
Dec 22 2015	ICPT	INTERCEPT PHARMACE ...	Shapiro David	CMO and EVP - Devel ...	Option Exercise	M	21.50	7,471	160,627	9,836
Dec 22 2015	ICPT	INTERCEPT PHARMACE ...	Shapiro David	CMO and EVP - Devel ...	Option Exercise	M	8.67	3,736	32,379	2,235
Dec 22 2015	ICPT	INTERCEPT PHARMACE ...	Shapiro David	CMO and EVP - Devel ...	Buy	M	31.90	219	6,986	39,821	39.6 K to 39.8 K (+0.55 %)
Dec 22 2015	ICPT	INTERCEPT PHARMACE ...	Shapiro David	CMO and EVP - Devel ...	Buy	M	21.50	7,471	160,627	39,602	32.1 K to 39.6 K (+23.25 %)
Dec 22 2015	ICPT	INTERCEPT PHARMACE ...	Shapiro David	CMO and EVP - Devel ...	Buy	M	8.67	3,736	32,379	32,131	28.4 K to 32.1 K (+13.16 %)
Dec 17 2015	ICPT	INTERCEPT PHARMACE ...	Shapiro David	CMO and EVP - Devel ...	Option Exercise	M	8.67	3,500	30,333	0
Dec 17 2015	ICPT	INTERCEPT PHARMACE ...	Shapiro David	CMO and EVP - Devel ...	Sell	S	157.45	1,000	157,450	28,395	29.4 K to 28.4 K (-3.40 %)
Dec 17 2015	ICPT	INTERCEPT PHARMACE ...	Shapiro David	CMO and EVP - Devel ...	Sell	S	157.38	2,500	393,450	29,395	31.9 K to 29.4 K (-7.84 %)
Dec 17 2015	ICPT	INTERCEPT PHARMACE ...	Shapiro David	CMO and EVP - Devel ...	Buy	M	8.67	3,500	30,333	31,895	28.4 K to 31.9 K (+12.33 %)
Nov 30 2015	ICPT	INTERCEPT PHARMACE ...	Bright Lisa	See Remarks	Sell	S	182.97	1,150	210,409	12,428	13.6 K to 12.4 K (-8.47 %)
Nov 27 2015	ICPT	INTERCEPT PHARMACE ...	AKKARAJU SRINIVAS	Director	Option Exercise	A	183.62	1,750	321,335	1,750
Nov 27 2015	ICPT	INTERCEPT PHARMACE ...	AKKARAJU SRINIVAS	Director	Grant	A	0.00	650	0	10,542	9.9 K to 10.5 K (+6.57 %)
Nov 27 2015	ICPT	INTERCEPT PHARMACE ...	SILVERSTEIN JONATHAN	Director	Option Exercise	A	183.62	1,750	321,335	1,750
Nov 27 2015	ICPT	INTERCEPT PHARMACE ...	SILVERSTEIN JONATHAN	Director	Grant	A	0.00	650	0	1,259	609 to 1.3 K (+106.73 %)
Nov 27 2015	ICPT	INTERCEPT PHARMACE ...	Fundaro Paolo	Director	Option Exercise	A	183.62	1,750	321,335	1,750
Nov 27 2015	ICPT	INTERCEPT PHARMACE ...	Fundaro Paolo	Director	Grant	A	0.00	650	0	8,871	8.2 K to 8.9 K (+7.91 %)
Nov 27 2015	ICPT	INTERCEPT PHARMACE ...	Benatti Luca	Director	Option Exercise	A	183.62	1,750	321,335	1,750
Nov 27 2015	ICPT	INTERCEPT PHARMACE ...	Benatti Luca	Director	Grant	A	0.00	650	0	1,942	1.3 K to 1.9 K (+50.31 %)
Nov 27 2015	ICPT	INTERCEPT PHARMACE ...	VEITINGER KLAUS R DR	Director	Option Exercise	A	183.62	1,750	321,335	1,750
Nov 27 2015	ICPT	INTERCEPT PHARMACE ...	VEITINGER KLAUS R DR	Director	Grant	A	0.00	650	0	2,816	2.2 K to 2.8 K (+30.01 %)
Nov 27 2015	ICPT	INTERCEPT PHARMACE ...	SBLENDORIO GLENN	Director	Option Exercise	A	183.62	1,750	321,335	1,750
Nov 27 2015	ICPT	INTERCEPT PHARMACE ...	SBLENDORIO GLENN	Director	Grant	A	0.00	650	0	1,102	452 to 1.1 K (+143.81 %)
Nov 27 2015	ICPT	INTERCEPT PHARMACE ...	SANTINI GINO	Director	Option Exercise	A	183.62	3,500	642,670	3,500
Nov 27 2015	ICPT	INTERCEPT PHARMACE ...	SANTINI GINO	Director	Grant	A	0.00	1,300	0	1,300	0 to 1.3 K
Nov 27 2015	ICPT	INTERCEPT PHARMACE ...	WELCH DANIEL G	Director	Option Exercise	A	183.62	3,500	642,670	3,500
Nov 27 2015	ICPT	INTERCEPT PHARMACE ...	WELCH DANIEL G	Director	Grant	A	0.00	1,300	0	1,300	0 to 1.3 K
Nov 23 2015	ICPT	INTERCEPT PHARMACE ...	WILLIAMS NICOLE	Director	Option Exercise	M	9.82	973	9,557	974
Nov 23 2015	ICPT	INTERCEPT PHARMACE ...	WILLIAMS NICOLE	Director	Sell	S	167.00	973	162,491	962	1.9 K to 962 (-50.28 %)
Nov 23 2015	ICPT	INTERCEPT PHARMACE ...	WILLIAMS NICOLE	Director	Buy	M	9.82	973	9,557	1,935	962 to 1.9 K (+101.14 %)
Nov 18 2015	ICPT	INTERCEPT PHARMACE ...	Shapiro David	CMO and EVP - Devel ...	Option Exercise	M	8.67	3,500	30,333	3,500
Nov 18 2015	ICPT	INTERCEPT PHARMACE ...	Shapiro David	CMO and EVP - Devel ...	Sell	S	179.49	1,500	269,235	28,395	29.9 K to 28.4 K (-5.02 %)
Nov 18 2015	ICPT	INTERCEPT PHARMACE ...	Shapiro David	CMO and EVP - Devel ...	Sell	S	178.00	2,764	492,002	29,895	32.7 K to 29.9 K (-8.46 %)
Nov 18 2015	ICPT	INTERCEPT PHARMACE ...	Shapiro David	CMO and EVP - Devel ...	Buy	M	8.67	3,500	30,333	32,659	29.2 K to 32.7 K (+12.00 %)
Nov 12 2015	ICPT	INTERCEPT PHARMACE ...	VEITINGER KLAUS R DR	Director	Option Exercise	M	21.50	1,000	21,500	5,972
Nov 12 2015	ICPT	INTERCEPT PHARMACE ...	VEITINGER KLAUS R DR	Director	Sell	S	198.25	1,000	198,250	2,166	3.2 K to 2.2 K (-31.59 %)
Nov 12 2015	ICPT	INTERCEPT PHARMACE ...	VEITINGER KLAUS R DR	Director	Buy	M	21.50	1,000	21,500	3,166	2.2 K to 3.2 K (+46.17 %)
Nov 12 2015	ICPT	INTERCEPT PHARMACE ...	Shapiro David	CMO and EVP - Devel ...	Option Exercise	M	8.67	3,500	30,333	7,000
Nov 12 2015	ICPT	INTERCEPT PHARMACE ...	Shapiro David	CMO and EVP - Devel ...	Sell	S	204.15	3,500	714,525	29,159	32.7 K to 29.2 K (-10.72 %)
Nov 12 2015	ICPT	INTERCEPT PHARMACE ...	Shapiro David	CMO and EVP - Devel ...	Buy	M	8.67	3,500	30,333	32,659	29.2 K to 32.7 K (+12.00 %)
Nov 04 2015	ICPT	INTERCEPT PHARMACE ...	McMinn Rachel	Chief Strategy Offi ...	Sell	S	160.24	125	20,029	8,218	8.3 K to 8.2 K (-1.50 %)
Oct 30 2015	ICPT	INTERCEPT PHARMACE ...	AKKARAJU SRINIVAS	Director	Option Exercise	M	21.50	1,250	26,875	3,999
Oct 30 2015	ICPT	INTERCEPT PHARMACE ...	AKKARAJU SRINIVAS	Director	Buy	M	21.50	1,250	26,875	9,892	8.6 K to 9.9 K (+14.46 %)
Oct 22 2015	ICPT	INTERCEPT PHARMACE ...	WILLIAMS NICOLE	Director	Option Exercise	M	9.82	974	9,567	1,947
Oct 22 2015	ICPT	INTERCEPT PHARMACE ...	WILLIAMS NICOLE	Director	Sell	S	182.22	974	177,482	962	1.9 K to 962 (-50.31 %)
Oct 22 2015	ICPT	INTERCEPT PHARMACE ...	WILLIAMS NICOLE	Director	Buy	M	9.82	974	9,567	1,936	962 to 1.9 K (+101.25 %)
Oct 05 2015	ICPT	INTERCEPT PHARMACE ...	Duncan Barbara Gayle	Chief Financial Off ...	Option Exercise	M	0.00	1,298	0	1,298
Oct 05 2015	ICPT	INTERCEPT PHARMACE ...	Duncan Barbara Gayle	Chief Financial Off ...	Option Exercise	M	8.67	1,000	8,667	6,940
Oct 05 2015	ICPT	INTERCEPT PHARMACE ...	Duncan Barbara Gayle	Chief Financial Off ...	Option Exercise	A	161.16	10,600	1,708,296	10,600
Oct 05 2015	ICPT	INTERCEPT PHARMACE ...	Duncan Barbara Gayle	Chief Financial Off ...	Sell	S	159.04	54	8,588	24,062	24.1 K to 24.1 K (-0.22 %)
Oct 05 2015	ICPT	INTERCEPT PHARMACE ...	Duncan Barbara Gayle	Chief Financial Off ...	Sell	S	163.39	1,000	163,390	24,116	25.1 K to 24.1 K (-3.98 %)
Oct 05 2015	ICPT	INTERCEPT PHARMACE ...	Duncan Barbara Gayle	Chief Financial Off ...	Buy	M	0.00	1,298	0	25,116	23.8 K to 25.1 K (+5.45 %)
Oct 05 2015	ICPT	INTERCEPT PHARMACE ...	Duncan Barbara Gayle	Chief Financial Off ...	Buy	M	8.67	1,000	8,667	23,818	22.8 K to 23.8 K (+4.38 %)
Oct 05 2015	ICPT	INTERCEPT PHARMACE ...	Duncan Barbara Gayle	Chief Financial Off ...	Grant	A	0.00	4,050	0	22,818	18.8 K to 22.8 K (+21.58 %)
Oct 05 2015	ICPT	INTERCEPT PHARMACE ...	Shapiro David	CMO and EVP - Devel ...	Option Exercise	M	0.00	1,622	0	1,623
Oct 05 2015	ICPT	INTERCEPT PHARMACE ...	Shapiro David	CMO and EVP - Devel ...	Option Exercise	A	161.16	13,100	2,111,196	13,100
Oct 05 2015	ICPT	INTERCEPT PHARMACE ...	Shapiro David	CMO and EVP - Devel ...	Sell	S	159.04	858	136,456	29,159	30 K to 29.2 K (-2.86 %)
Oct 05 2015	ICPT	INTERCEPT PHARMACE ...	Shapiro David	CMO and EVP - Devel ...	Sell	S	163.39	282	46,076	30,017	30.3 K to 30 K (-0.93 %)
Oct 05 2015	ICPT	INTERCEPT PHARMACE ...	Shapiro David	CMO and EVP - Devel ...	Buy	M	0.00	1,622	0	30,299	28.7 K to 30.3 K (+5.66 %)
Oct 05 2015	ICPT	INTERCEPT PHARMACE ...	Shapiro David	CMO and EVP - Devel ...	Grant	A	0.00	5,150	0	28,677	23.5 K to 28.7 K (+21.89 %)
Oct 05 2015	ICPT	INTERCEPT PHARMACE ...	Adorini Luciano	Chief Scientific Of ...	Option Exercise	M	0.00	649	0	649
Oct 05 2015	ICPT	INTERCEPT PHARMACE ...	Adorini Luciano	Chief Scientific Of ...	Option Exercise	A	161.16	3,250	523,770	3,250
Oct 05 2015	ICPT	INTERCEPT PHARMACE ...	Adorini Luciano	Chief Scientific Of ...	Buy	M	0.00	649	0	12,608	12 K to 12.6 K (+5.43 %)
Oct 05 2015	ICPT	INTERCEPT PHARMACE ...	Adorini Luciano	Chief Scientific Of ...	Grant	A	0.00	1,250	0	11,959	10.7 K to 12 K (+11.67 %)
Oct 05 2015	ICPT	INTERCEPT PHARMACE ...	Pruzanski Mark	CEO & President	Option Exercise	M	0.00	4,867	0	4,868
Oct 05 2015	ICPT	INTERCEPT PHARMACE ...	Pruzanski Mark	CEO & President	Option Exercise	A	161.16	32,550	5,245,758	32,550
Oct 05 2015	ICPT	INTERCEPT PHARMACE ...	Pruzanski Mark	CEO & President	Sell	S	159.04	167	26,560	526,814	527 K to 526.8 K (-0.03 %)
Oct 05 2015	ICPT	INTERCEPT PHARMACE ...	Pruzanski Mark	CEO & President	Buy	M	0.00	4,867	0	526,981	522.1 K to 527 K (+0.93 %)
Oct 05 2015	ICPT	INTERCEPT PHARMACE ...	Pruzanski Mark	CEO & President	Grant	A	0.00	15,100	0	522,114	507 K to 522.1 K (+2.98 %)
Oct 05 2015	ICPT	INTERCEPT PHARMACE ...	McMinn Rachel	Chief Strategy Offi ...	Option Exercise	A	161.16	10,600	1,708,296	10,600
Oct 05 2015	ICPT	INTERCEPT PHARMACE ...	McMinn Rachel	Chief Strategy Offi ...	Grant	A	0.00	4,050	0	8,343	4.3 K to 8.3 K (+94.34 %)
Oct 05 2015	ICPT	INTERCEPT PHARMACE ...	Bright Lisa	See Remarks	Option Exercise	A	161.16	13,450	2,167,602	13,450
Oct 05 2015	ICPT	INTERCEPT PHARMACE ...	Bright Lisa	See Remarks	Grant	A	0.00	5,200	0	13,578	8.4 K to 13.6 K (+62.07 %)
Sep 23 2015	ICPT	INTERCEPT PHARMACE ...	WILLIAMS NICOLE	Director	Option Exercise	M	9.82	973	9,557	2,921
Sep 23 2015	ICPT	INTERCEPT PHARMACE ...	WILLIAMS NICOLE	Director	Sell	S	194.82	973	189,560	962	1.9 K to 962 (-50.28 %)
Sep 23 2015	ICPT	INTERCEPT PHARMACE ...	WILLIAMS NICOLE	Director	Buy	M	9.82	973	9,557	1,935	962 to 1.9 K (+101.14 %)
Sep 17 2015	ICPT	INTERCEPT PHARMACE ...	Shapiro David	CMO and EVP - Devel ...	Option Exercise	M	8.67	5,294	45,882	10,500
Sep 17 2015	ICPT	INTERCEPT PHARMACE ...	Shapiro David	CMO and EVP - Devel ...	Option Exercise	M	8.67	3,500	30,333	15,794
Sep 17 2015	ICPT	INTERCEPT PHARMACE ...	Shapiro David	CMO and EVP - Devel ...	Sell	S	192.85	1,500	289,275	23,527	25 K to 23.5 K (-5.99 %)
Sep 17 2015	ICPT	INTERCEPT PHARMACE ...	Shapiro David	CMO and EVP - Devel ...	Sell	S	191.04	1,000	191,044	25,027	26 K to 25 K (-3.84 %)
Sep 17 2015	ICPT	INTERCEPT PHARMACE ...	Shapiro David	CMO and EVP - Devel ...	Sell	S	189.16	1,000	189,161	26,027	27 K to 26 K (-3.70 %)
Sep 17 2015	ICPT	INTERCEPT PHARMACE ...	Shapiro David	CMO and EVP - Devel ...	Buy	M	8.67	5,294	45,882	27,027	21.7 K to 27 K (+24.36 %)
Sep 17 2015	ICPT	INTERCEPT PHARMACE ...	Shapiro David	CMO and EVP - Devel ...	Buy	M	8.67	3,500	30,333	21,733	18.2 K to 21.7 K (+19.20 %)
Sep 11 2015	ICPT	INTERCEPT PHARMACE ...	VEITINGER KLAUS R DR	Director	Option Exercise	M	21.50	500	10,750	6,972
Sep 11 2015	ICPT	INTERCEPT PHARMACE ...	VEITINGER KLAUS R DR	Director	Sell	S	198.25	500	99,125	2,166	2.7 K to 2.2 K (-18.75 %)

Page: < prev 1 ... 2 3 4 5 6 7 8 9 ... 13 next >